However, the chemokines and their receptors that particularly stimulate tumorigenesis, including CCR7, CXCL1, CXCL8, and CXCL12/CXCR4, could, consequently, act as poor prognostic markers for cancer patients. The gene discussed is CXCR4; the disease is cancer.